Astellas acts to block Sandoz's generic Prograf in Canada
This article was originally published in Scrip
Executive Summary
Astellas has taken legal action against Sandoz in Canada after the Novartis generics operation filed an abbreviated submission for the approval of its generic version of Prograf (tacrolimus).